ArticleFrontiers in public health2026
Epidemiological surveillance of childhood and adolescent malignancies as a tool for public health strategy: insights from the Polish National Cancer Registry 2023.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric malignancies require specialized epidemiological surveillance due to their distinct developmental etiology and unique societal impact. In the context of contemporary European demographic trends, characterized by sub-replacement fertility, monitoring health outcomes in younger cohorts has become a strategic public health priority. Methods: This population-based retrospective analysis evaluates the incidence and epidemiological patterns of childhood and adolescent malignancies in Poland in 2023, utilizing Polish National Cancer Registry (PNCR) data to provide an evidence base for health policy optimization. Results: Among the 1,229 new cases recorded (782 in the 0-14 cohort), a bimodal age distribution peaked at 0-4 and 15-19 years. While the aggregate gender burden was balanced [Incidence Rate Ratio (IRR) = 1.01], significant biological disparities occurred in specific subtypes, notably a marked female predominance in thyroid carcinoma and an extreme male predilection in Burkitt lymphoma (IRR = 10.43 in the 0-14 group). Descriptive long-term trend analysis suggests an upward trajectory in incidence, with an observed localized peak in 2021-2022. Discussion: Given current demographic constraints, with Poland's fertility rate (1.2) significantly below the EU average, these malignancies represent a disproportionate loss of future human capital. Our findings underscore that pediatric oncological care is a high-efficiency investment with a substantial social return. We advocate for the establishment of a dedicated pediatric registry integrated with molecular-genetic data, which is essential for the transition toward precision oncology and the strategic allocation of resources to mitigate the long-term socio-economic impact of these malignancies on the population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.